MTHFD1 promoter hypermethylation increases the risk of hypertension.

CONCLUSIONS: MTHFD1 promoter hypermethylation was a potential biomarker for the diagnosis of essential hypertension. PMID: 30183434 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Hypertension - Category: Cardiology Authors: Tags: Clin Exp Hypertens Source Type: research
More News: Hypertension | Study